Intensive Meditation Intervention Aids Schizophrenia Symptoms
By Lori Solomon HealthDay Reporter
WEDNESDAY, Feb. 14, 2024 -- An intensive meditation-based intervention (iMI) significantly improves positive symptoms, particularly refractory hallucinations and delusions, in male patients with schizophrenia, according to a study published online Feb. 6 in Psychiatry and Clinical Neurosciences.
Ting Xue, Ph.D., from the Shanghai Mental Health Center at Shanghai Jiao Tong University, and colleagues investigated the impact of an eight-month daily guided iMI on persistent hallucinations/delusions and health-related quality of life in 64 male inpatients with schizophrenia with treatment-refractory hallucinations and delusions.
The researchers found that iMI significantly reduced Positive and Negative Syndrome Scale total scores and improved positive symptoms and hallucination/delusion items versus a general rehabilitation program at both three and eight months. At eight months, treatment response rates (≥25 percent reduction) for these measures significantly increased in the iMI group. Additionally, iMI significantly increased scores in physical activity and mindfulness skills at both time points compared with general rehabilitation, with a more pronounced effect observed at eight months.
"The findings support iMI as a promising adjunctive therapy alongside antipsychotic medications, particularly for individuals with positive symptoms in clinical settings," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
One in Nine U.S. Children Have Ever Been Diagnosed With ADHD
THURSDAY, May 23, 2024 -- Diagnoses of attention-deficit/hyperactivity disorder (ADHD) in U.S. children continue to increase, with approximately one in nine having ever received a...
2024 ASCO Annual Meeting to Focus on Clinical Cancer Research Impacting Patient Care
THURSDAY, May 23, 2024 -- The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held May 31 to June 4, 2024, in Chicago and online. The theme of this...
Socioeconomic Status Transitions Tied to Dementia Risk
THURSDAY, May 23, 2024 -- Upward and downward socioeconomic status (SES) transitions are associated with the risk for dementia and the length of dementia-free periods during the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.